3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
7
Withdrawn
1
Terminated
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Multiple Myeloma
16
Lymphoma
7
Neoplasms, Plasma Cell
5
Lymphoma, Large B-Cell, Diffuse
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Melanoma
3
Lymphoma, Mantle-Cell
3
Lymphoma, Follicular
3
Leukemia, Myeloid, Acute
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Leukemia
3
Waldenstrom Macroglobulinemia
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large-Cell, Immunoblastic
2
Lymphoma, B-Cell, Marginal Zone
2
Immunoblastic Lymphadenopathy
2
Hodgkin Disease
2
Burkitt Lymphoma
2
Skin Neoplasms
1
Sezary Syndrome
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdoid Tumor
1
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neuroectodermal Tumors, Primitive
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Interventions
selinexor
1
liposomal doxorubicin
1
ixazomib
1
fludarabine phosphate
1
Temozolomide
1
PM 01183
1
Melphalan
1
Irinotecan
1
Erlotinib Hydrochloride
1
Electroacupuncture
1
Busulfan
1
Biopsy, Fine-Needle
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Sarcoma, Ewing
×
Melphalan
×
Clear all
NCT01969942
2017-05-09
ASCT
University of Louisville
Phase 1
Withdrawn